SARAH MILLS: Open Payments
NPI 1831417534 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,314 in 107 payments from 37 companies in 2025. Trend: 2023 $1,437 · 2024 $1,654 · 2025 $2,314
Food & beverage: $2,200Education: $114
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $219 |
| Genentech USA, Inc. | 9 | $157 |
| Novartis Pharmaceuticals Corporation | 12 | $156 |
| TerSera Therapeutics LLC | 6 | $155 |
| BeOne Medicines USA, Inc. | 8 | $154 |
| ABBVIE INC. | 7 | $141 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Eisai Inc. | 4 | $100 |
| Lilly USA, LLC | 4 | $99 |
| Merck Sharp & Dohme LLC | 4 | $90 |
Products named: Zoladex, KISQALI, ERLEADA, Lenvima, KEYTRUDA, BRUKINSA, DATROWAY, TEVIMBRA.
Industry payments across MI — which companies pay providers there.
